Ex-Date | Pay Date | Amount | Change |
---|---|---|---|
₩10 | 0% | ||
₩10 | 0% | ||
₩10 | 0% | ||
₩10 | 0% | ||
₩10 |
Kukjeon Pharmaceutical Co Ltd Ordinary Shares pays a dividend yield (FWD) of 0.31%.
- ISIN
- WKN
- -
- Symbol / Exchange
- / XKRX
- Value
- €2.05
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
South Korea
- Dividend Currency
- South Korean Won
- Within the last 12 months, Kukjeon Pharmaceutical Co Ltd Ordinary Shares paid a dividend of ₩10. For the next 12 months, Kukjeon Pharmaceutical Co Ltd Ordinary Shares is expected to pay a dividend of ₩10. This corresponds to a dividend yield of approximately 0.31%.
- The dividend yield of Kukjeon Pharmaceutical Co Ltd Ordinary Shares is currently 0.31%.
- Kukjeon Pharmaceutical Co Ltd Ordinary Shares pays annually dividends. Payout is in April.
- The next dividend will be paid on 28 April 2025.
- Within the last 10 years, Kukjeon Pharmaceutical Co Ltd Ordinary Shares has paid dividends in 2 of them.
- Dividends of ₩10 are expected for the next 12 months. This corresponds to a dividend yield of 0.31%.
- Kukjeon Pharmaceutical Co Ltd Ordinary Shares is assigned to the sector "Health Care".
- There are currently no known stock splits for Kukjeon Pharmaceutical Co Ltd Ordinary Shares.
- In order to receive the future dividend from Kukjeon Pharmaceutical Co Ltd Ordinary Shares on 28 April 2025 you must have purchased your Kukjeon Pharmaceutical Co Ltd Ordinary Shares shares before the ex-date on 27 December 2024.
- To receive the last dividend of Kukjeon Pharmaceutical Co Ltd Ordinary Shares on 25 April 2024 in the amount of ₩10 you had to have the stock in your portfolio before the ex-day on 27 December 2023.
- The last dividend was paid on 25 April 2024.
- In 2022, dividends of ₩10 were paid by Kukjeon Pharmaceutical Co Ltd Ordinary Shares.
- Dividends from Kukjeon Pharmaceutical Co Ltd Ordinary Shares are paid in South Korean Won.
- The headquarters of Kukjeon Pharmaceutical Co Ltd Ordinary Shares is located in South Korea.